Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nian Dong

Showing results (51-60 of 70) with videos related to

Pageof 7
Sort By:
Bioorganic Chemistry|November 24, 2024
Design, synthesis, and biological evaluation of novel AAK1/HDACs dual inhibitors against SARS-CoV-2 entryNian-Dong Mao, Yueying Xu, Xia Yao, et al.
Chemmedchem|May 1, 2023
Design, Synthesis and Biological Evaluation of Histone Deacetylase Inhibitors Based on Pyrrolo[2,3-d]pyrimidine and Pyrrolo[2,3-b]pyridine ScaffoldsNian-Dong Mao, Yuan Gao, Xia-Wen Dang, et al.
European Journal of Medicinal Chemistry|July 10, 2025
Poly(ADP-ribose) polymerase-1 (PARP1)-based dual inhibitors targeting cancer synthetic lethality (2022-present): advances and perspectivesGuo-Wei Ye, Yu-Qing Zhang, Meng-Lan He, et al.
Molecular Diversity|April 2, 2025
Discovery and optimization of AAK1 inhibitors based on 1H-indazole scaffold for the potential treatment of SARS-CoV-2 infectionZi Hui, Haowen Deng, Yueying Xu, et al.
IEEE Transactions on Nanotechnology|February 14, 2020
Optimization of Protein-Protein Interaction Measurements for Drug Discovery Using AFM Force SpectroscopyYongliang Yang, Bixi Zeng, Zhiyong Sun, et al.
Journal of Translational Medicine|September 10, 2015
STAT1 modification improves therapeutic effects of interferons on lung cancer cellsJunjie Chen, Jialu Zhao, Lefu Chen, et al.
Molecular Carcinogenesis|June 23, 2025
Mitochondrial Energy Metabolic Reprogramming Facilitates the Malignant Progression of Intrahepatic CholangiocarcinomaJun-Long Wang, Yu-Chen Pei, Qi-Zhi Liang, et al.
Scientific Reports|March 8, 2017
Anordrin Eliminates Tamoxifen Side Effects without Changing Its Antitumor ActivityWenwen Gu, Wenping Xu, Xiaoxi Sun, et al.
Microbial Drug Resistance (Larchmont, N.Y.)|April 22, 2022
Dissemination of <i>bla</i><sub>NDM-5</sub> in <i>Escherichia coli</i> through the IncX3 Plasmid from Different Regions in ChinaXiaofeng Hu, Lang Yang, Nian Dong, et al.
Plos One|April 4, 2018
Dominant serotype distribution and antimicrobial resistance profile of Shigella spp. in Xinjiang, ChinaHongbo Liu, Binghua Zhu, Shaofu Qiu, et al.
Pageof 7

Showing results (51-60 of 70) with videos related to

Sort By:
Pageof 7
Bioorganic Chemistry|November 24, 2024
Design, synthesis, and biological evaluation of novel AAK1/HDACs dual inhibitors against SARS-CoV-2 entryNian-Dong Mao, Yueying Xu, Xia Yao, et al.
Chemmedchem|May 1, 2023
Design, Synthesis and Biological Evaluation of Histone Deacetylase Inhibitors Based on Pyrrolo[2,3-d]pyrimidine and Pyrrolo[2,3-b]pyridine ScaffoldsNian-Dong Mao, Yuan Gao, Xia-Wen Dang, et al.
European Journal of Medicinal Chemistry|July 10, 2025
Poly(ADP-ribose) polymerase-1 (PARP1)-based dual inhibitors targeting cancer synthetic lethality (2022-present): advances and perspectivesGuo-Wei Ye, Yu-Qing Zhang, Meng-Lan He, et al.
Molecular Diversity|April 2, 2025
Discovery and optimization of AAK1 inhibitors based on 1H-indazole scaffold for the potential treatment of SARS-CoV-2 infectionZi Hui, Haowen Deng, Yueying Xu, et al.
IEEE Transactions on Nanotechnology|February 14, 2020
Optimization of Protein-Protein Interaction Measurements for Drug Discovery Using AFM Force SpectroscopyYongliang Yang, Bixi Zeng, Zhiyong Sun, et al.
Journal of Translational Medicine|September 10, 2015
STAT1 modification improves therapeutic effects of interferons on lung cancer cellsJunjie Chen, Jialu Zhao, Lefu Chen, et al.
Molecular Carcinogenesis|June 23, 2025
Mitochondrial Energy Metabolic Reprogramming Facilitates the Malignant Progression of Intrahepatic CholangiocarcinomaJun-Long Wang, Yu-Chen Pei, Qi-Zhi Liang, et al.
Scientific Reports|March 8, 2017
Anordrin Eliminates Tamoxifen Side Effects without Changing Its Antitumor ActivityWenwen Gu, Wenping Xu, Xiaoxi Sun, et al.
Microbial Drug Resistance (Larchmont, N.Y.)|April 22, 2022
Dissemination of <i>bla</i><sub>NDM-5</sub> in <i>Escherichia coli</i> through the IncX3 Plasmid from Different Regions in ChinaXiaofeng Hu, Lang Yang, Nian Dong, et al.
Plos One|April 4, 2018
Dominant serotype distribution and antimicrobial resistance profile of Shigella spp. in Xinjiang, ChinaHongbo Liu, Binghua Zhu, Shaofu Qiu, et al.
Pageof 7